Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century

被引:81
作者
Garden, Adam S. [1 ]
Kies, Merrill S. [2 ]
Morrison, William H. [1 ]
Weber, Randal S. [3 ]
Frank, Steven J. [1 ]
Glisson, Bonnie S. [2 ]
Gunn, Gary B. [1 ]
Beadle, Beth M. [1 ]
Ang, K. Kian [1 ]
Rosenthal, David I. [1 ]
Sturgis, Erich M. [3 ,4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA
关键词
Radiation; Oropharyngeal cancer; IMRT; Chemoradiation; Squamous cell; SQUAMOUS-CELL CARCINOMA; INTENSITY-MODULATED RADIOTHERAPY; CONCOMITANT BOOST RADIATION; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; HEAD; CISPLATIN; SURVIVAL; THERAPY; DOCETAXEL;
D O I
10.1186/1748-717X-8-21
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We performed this study to assess outcomes of patients with oropharyngeal cancer treated with modern therapy approaches. Methods: Demographics, treatments and outcomes of patients diagnosed with Stage 3-4B squamous carcinoma of the oropharynx, between 2000 - 2007 were tabulated and analyzed. Results: The cohort consisted of 1046 patients. The 5- year actuarial overall survival, recurrence-free survival and local-regional control rates for the entire cohort were 78%, 77% and 87% respectively. More advanced disease, increasing T-stage and smoking were associated with higher rates of local-regional recurrence and poorer survival. Conclusions: Patients with locally advanced oropharyngeal cancer have a relatively high survival rate. Patients' demographics and primary tumor volume were very influential on these favorable outcomes. In particular, patients with small primary tumors did very well even when treatment was not intensified with the addition of chemotherapy.
引用
收藏
页数:10
相关论文
共 33 条
[11]   MULTI-INSTITUTIONAL TRIAL OF ACCELERATED HYPOFRACTIONATED INTENSITY-MODULATED RADIATION THERAPY FOR EARLY-STAGE OROPHARYNGEAL CANCER (RTOG 00-22) [J].
Eisbruch, Avraham ;
Harris, Jonathan ;
Garden, Adam S. ;
Chao, Clifford K. S. ;
Straube, William ;
Harari, Paul M. ;
Sanguineti, Giuseppe ;
Jones, Christopher U. ;
Bosch, Walter R. ;
Ang, K. Kian .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (05) :1333-1338
[12]   Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial [J].
Fakhry, Carole ;
Westra, William H. ;
Cmelak, Sigui Li Anthony ;
Ridge, John A. ;
Pinto, Harlan ;
Forastiere, Arlene ;
Gillison, Maura L. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (04) :261-269
[13]   A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003 [J].
Fu, KK ;
Pajak, TF ;
Trotti, A ;
Jones, CU ;
Spencer, SA ;
Phillips, TL ;
Garden, AS ;
Ridge, JA ;
Cooper, JS ;
Ang, KK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01) :7-16
[14]   Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: A Phase II trial of the Radiation Therapy Oncology Group (RTOG 99-14) [J].
Garden, Adam S. ;
Harris, Jonathan ;
Trotti, Andy ;
Jones, Christopher U. ;
Carrascosa, Luis ;
Cheng, Jonathan D. ;
Spencer, Sharon S. ;
Forastiere, Arlene ;
Weber, Randal S. ;
Ang, K. Kian .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (05) :1351-1355
[15]   Is concurrent chemoradiation the treatment of choice for all patients with stage III or IV head and neck carcinoma? [J].
Garden, AS ;
Asper, JA ;
Morrison, WH ;
Schechter, NR ;
Glisson, BS ;
Kies, MS ;
Myers, JN ;
Ang, KK .
CANCER, 2004, 100 (06) :1171-1178
[16]   Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal Cancer [J].
Gillison, Maura L. ;
Zhang, Qiang ;
Jordan, Richard ;
Xiao, Weihong ;
Westra, William H. ;
Trotti, Andy ;
Spencer, Sharon ;
Harris, Jonathan ;
Chung, Christine H. ;
Ang, K. Kian .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (17) :2102-2111
[17]  
Groome PA, 2001, CANCER, V92, P1484, DOI 10.1002/1097-0142(20010915)92:6<1484::AID-CNCR1473>3.0.CO
[18]  
2-W
[19]   Evaluation of Trends in the Use of Intensity-Modulated Radiotherapy for Head and Neck Cancer From 2000 Through 2005 [J].
Guadagnolo, B. Ashleigh ;
Liu, Chih-Chin ;
Cormier, Janice N. ;
Du, Xianglin L. .
CANCER, 2010, 116 (14) :3505-3512
[20]   Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa [J].
Gwozdz, JT ;
Morrison, WH ;
Garden, AS ;
Weber, RS ;
Peters, LJ ;
Ang, KK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (01) :127-135